Oral Small Molecule Amylin Receptor Agonist ASC39 Demonstrated Eloralintide-like Amylin Selectivity and Efficacy in Preclinical Models PressReach · Mar 17, 2026
Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026 and Hold Online Earnings Call PressReach · Mar 16, 2026
From Liver to Lymph Support: How PureHealth Research is Leading the Charge in Premium Pure Health Products PressReach · Mar 15, 2026
Dr. David Pincus of Pincus Plastic Surgery Launches $1,000 Scholarship to Support Future Leaders in Plastic Surgery PressReach · Mar 14, 2026
Calumet Announces Pricing of $150 Million Private Placement of Additional 9.75% Senior Notes due 2031 PressReach · Mar 13, 2026
New report reveals how businesses can reclaim $53 billion lost to preventable AP errors PressReach · Mar 12, 2026
Banyan Tree Deepens Wellbeing Experiences with Expansion of its Signature Connections Programme, New Retreats, Visiting Practitioners and Global Partnership with Manduka PressReach · Mar 10, 2026
Phothera Launches Guided Mode for Home Phototherapy Treatments for Chronic Skin Conditions PressReach · Mar 9, 2026
PureHealth Research Launches Doctor-Approved Natural GLP-1 Supplements Collection for Metabolic Support PressReach · Mar 8, 2026
U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China PressReach · Mar 7, 2026
